PL368989A1 - Human tissue factor antibodies - Google Patents

Human tissue factor antibodies

Info

Publication number: PL368989A1
Authority: PL; Poland
Prior art keywords: human tissue; tissue factor; factor antibodies; antibodies; human
Prior art date: 2001-10-02

Application number

PL02368989A

Other languages

English (en)

Polish (pl)

Inventor

Per-Ola Freskgaard

Jes Thorn Clausen

Brit Binow Sorensen

Marianne Kjalke

Original Assignee

Novo Nordisk A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-02

Filing date

2002-09-30

Publication date

2005-04-04

2002-09-30 Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S

2005-04-04 Publication of PL368989A1 publication Critical patent/PL368989A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Zoology (AREA)
Toxicology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

PL02368989A 2001-10-02 2002-09-30 Human tissue factor antibodies PL368989A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200101437		2001-10-02

Publications (1)

Publication Number	Publication Date
PL368989A1 true PL368989A1 (en)	2005-04-04

Family

ID=8160743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02368989A PL368989A1 (en)	2001-10-02	2002-09-30	Human tissue factor antibodies

Country Status (15)

Country	Link
EP (1)	EP1434802A1 (xx)
JP (1)	JP2005512970A (xx)
KR (1)	KR20040045478A (xx)
CN (1)	CN1575302A (xx)
BR (1)	BR0213046A (xx)
CA (1)	CA2460917A1 (xx)
CZ (1)	CZ2004454A3 (xx)
HU (1)	HUP0401658A2 (xx)
IL (1)	IL160998A0 (xx)
MX (1)	MXPA04003051A (xx)
NO (1)	NO20041802L (xx)
PL (1)	PL368989A1 (xx)
RU (1)	RU2004113373A (xx)
WO (1)	WO2003029295A1 (xx)
ZA (1)	ZA200402303B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060235209A9 (en)	1997-03-10	2006-10-19	Jin-An Jiao	Use of anti-tissue factor antibodies for treating thromboses
US20030109680A1 (en)	2001-11-21	2003-06-12	Sunol Molecular Corporation	Antibodies for inhibiting blood coagulation and methods of use thereof
US5986065A (en)	1997-03-10	1999-11-16	Sunol Molecular Corporation	Antibodies for inhibiting blood coagulation and methods of use thereof
US7749498B2 (en)	1997-03-10	2010-07-06	Genentech, Inc.	Antibodies for inhibiting blood coagulation and methods of use thereof
EP1374896A4 (en) *	2001-03-26	2005-04-06	Koji Suzuki	MEANS TO IMPROVE THE FLUID CHARACTERISTICS OF BLOOD
AU2003277832A1 (en) *	2002-10-31	2004-05-25	Novo Nordisk A/S	Humanized tissue factor antibodies
EP1587549A2 (en) *	2003-01-22	2005-10-26	Novo Nordisk A/S	Radiolabelled tissue factor binding agent and the use thereof
KR20060035608A (ko) *	2003-05-30	2006-04-26	센토코 인코포레이티드	항 조직 인자 항체로 종양 성장을 저해하는 방법
US7605235B2 (en)	2003-05-30	2009-10-20	Centocor, Inc.	Anti-tissue factor antibodies and compositions
US9708410B2 (en)	2003-05-30	2017-07-18	Janssen Biotech, Inc.	Anti-tissue factor antibodies and compositions
ES2527102T3 (es) *	2003-06-19	2015-01-20	Genentech, Inc.	Composiciones y métodos para el tratamiento de trastornos relacionados con la coagulación
AU2004268648A1 (en) *	2003-08-29	2005-03-10	Centocor, Inc.	Method of promoting graft survival with anti-tissue factor antibodies
EP1744734A2 (en) *	2004-02-20	2007-01-24	Novo Nordisk A/S	Therapeutic combination comprising a tissue factor antagonist and anti-cancer compounds
CN101512008B (zh)	2006-09-08	2015-04-01	艾伯维巴哈马有限公司	白介素-13结合蛋白
CN101423552B (zh) *	2008-02-29	2012-05-16	复旦大学	一种人源抗人组织因子Fab及其制备方法
AU2013203150B2 (en) *	2008-12-09	2016-09-22	Genmab A/S	Human antibodies against tissue factor
UA109633C2 (uk) *	2008-12-09	2015-09-25		Антитіло людини проти тканинного фактора
AU2016277670B2 (en) *	2008-12-09	2019-02-07	Genmab A/S	Human antibodies against tissue factor
WO2010131235A1 (en) *	2009-05-15	2010-11-18	University Of The Free State	Inhibitory antibody fragments to human tissue factor
KR101935058B1 (ko)	2010-06-15	2019-01-03	젠맵 에이/에스	조직 인자에 대한 인간 항체 약물 접합체
US8722044B2 (en)	2011-03-15	2014-05-13	Janssen Biotech, Inc.	Human tissue factor antibody and uses thereof
WO2017028823A1 (zh) *	2015-08-20	2017-02-23	复旦大学	靶向于组织因子的抗体、其制备方法和用途
EP3502141A4 (en) *	2016-08-22	2020-04-08	Fudan University	TISSUE FACTOR TARGET ANTIBODIES, PREPARATION METHOD AND USE THEREOF

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5223427A (en) *	1987-03-31	1993-06-29	The Scripps Research Institute	Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain
US6001978A (en) *	1987-03-31	1999-12-14	The Scripps Research Institute	Human tissue factor related DNA segments polypeptides and antibodies
JP2779193B2 (ja) *	1989-02-02	1998-07-23	帝人株式会社	抗ヒト組織因子モノクローナル抗体
DK0833911T3 (da) *	1995-06-07	2004-08-30	Ortho Mcneil Pharm Inc	CDR-transplanterede anti-vævsfaktorantistoffer og fremgangsmåder til anvendelse deraf
TR200101541T2 (tr) *	1998-04-03	2002-06-21	Chugai Seiyaku Kabushiki Kaisha	İnsan doku faktörüne (TF) karşı insanlaştırılmış antikor.
CZ20021035A3 (cs) *	1999-10-01	2002-08-14	Chugai Seiyaku Kabushiki Kaisha	Prevence a léčba nemocí souvisejících s poruchami krevní sráľlivosti
JP2003527861A (ja) *	2000-03-16	2003-09-24	ジェネンテック・インコーポレーテッド	増強した抗血液凝固能を持つ抗組織因子抗体

2002
- 2002-09-30 RU RU2004113373/13A patent/RU2004113373A/ru not_active Application Discontinuation
- 2002-09-30 BR BR0213046-7A patent/BR0213046A/pt not_active IP Right Cessation
- 2002-09-30 EP EP02800043A patent/EP1434802A1/en not_active Withdrawn
- 2002-09-30 CN CNA028208463A patent/CN1575302A/zh active Pending
- 2002-09-30 WO PCT/DK2002/000644 patent/WO2003029295A1/en not_active Application Discontinuation
- 2002-09-30 PL PL02368989A patent/PL368989A1/xx not_active Application Discontinuation
- 2002-09-30 MX MXPA04003051A patent/MXPA04003051A/es unknown
- 2002-09-30 IL IL16099802A patent/IL160998A0/xx unknown
- 2002-09-30 CZ CZ2004454A patent/CZ2004454A3/cs unknown
- 2002-09-30 HU HU0401658A patent/HUP0401658A2/hu unknown
- 2002-09-30 JP JP2003532540A patent/JP2005512970A/ja not_active Withdrawn
- 2002-09-30 KR KR10-2004-7004942A patent/KR20040045478A/ko not_active Application Discontinuation
- 2002-09-30 CA CA002460917A patent/CA2460917A1/en not_active Abandoned
2004
- 2004-03-24 ZA ZA200402303A patent/ZA200402303B/en unknown
- 2004-04-30 NO NO20041802A patent/NO20041802L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20041802L (no)	2004-04-30
CA2460917A1 (en)	2003-04-10
RU2004113373A (ru)	2005-03-27
WO2003029295A1 (en)	2003-04-10
IL160998A0 (en)	2004-08-31
EP1434802A1 (en)	2004-07-07
MXPA04003051A (es)	2004-07-05
KR20040045478A (ko)	2004-06-01
JP2005512970A (ja)	2005-05-12
BR0213046A (pt)	2005-06-28
ZA200402303B (en)	2004-11-25
CZ2004454A3 (cs)	2004-09-15
HUP0401658A2 (hu)	2004-11-29
CN1575302A (zh)	2005-02-02

Publication	Publication Date	Title
IL160998A0 (en)	2004-08-31	Human tissue factor antibodies
HUP0500816A3 (en)	2010-01-28	Antagonistic anti-htnfsf13b human antibodies
EP1414845A4 (en)	2009-07-08	SEPARATE HUMAN PROTEINS
GB0106588D0 (en)	2001-05-09	Tissue distracter
EP1506398A4 (en)	2005-06-29	HUMAN SECRETED PROTEINS
GB0218205D0 (en)	2002-09-11	Human ZZAP1 protein
AU2003226899A8 (en)	2003-09-29	Human diabetes-mediating proteins
HUP0402334A3 (en)	2007-03-28	Modified human growth hormone
AU2003287016A8 (en)	2004-04-23	Human sarcoma-associated antigens
GB0410094D0 (en)	2004-06-09	Human RAS interacting protein
GB0410147D0 (en)	2004-06-09	Human angiomotin-like protein 1
GB0226332D0 (en)	2002-12-18	Skin preparation
AU2002257630A1 (en)	2002-09-24	Human mrp5-like protein
AU148103S (en)	2002-06-06	Tissue
GB0201681D0 (en)	2002-03-13	Human ralgds-like protein 3
GB0116885D0 (en)	2001-09-05	Tissue implant
GB0116888D0 (en)	2001-09-05	Tissue implant
GB0116886D0 (en)	2001-09-05	Tissue implant
TWI315313B (en)	2009-10-01	Human coagulation factor vii variants
GB0110881D0 (en)	2001-06-27	Medical use
GB0119193D0 (en)	2001-09-26	Medical use
GB0403414D0 (en)	2004-03-24	Four human zinc-finger-containing proteins:MDZ3,MDZ4,MDZ7 and MDZ12
AU145797S (en)	2001-11-02	Medical dressing
AU146972S (en)	2002-03-08	Disposable neckerchief
GB0201011D0 (en)	2002-03-06	Human gtp-rho binding protein 2

Legal Events

Date	Code	Title	Description
2010-08-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)